Medicare Enrolled
Dr. Jay Lafleur, MD
Anesthesiology · Pearland, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lafleur from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lafleur?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lafleur
Dr. Jay Lafleur is an anesthesiology specialist in Pearland, TX, with 18 years of NPI registration. Based on federal Medicare data, Dr. Lafleur performed 6,178.5 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Lafleur received a total of $20,627 from 65 pharmaceutical and/or device companies across 436 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lafleur is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years of NPI registration
▲ Top 1% volume in TX
$20,627 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗6,178.5
Medicare services
Top 1% in TX for anesthesiology
Not available
Unique patients (not deduplicated)
$36
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Bupivacaine injection, 0.5 mg An injection of bupivacaine, a local anesthetic, administered in a dose of 0.5 mg. |
1,380 | $0 | $1 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,193 | $64 | $236 |
| Midazolam injection, per 1 mg Administration of midazolam hydrochloride, a sedative medication, measured in 1 mg increments. |
1,102.5 | $0 | $10 |
| Drug screening test A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample. |
709 | $57 | $343 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
279 | $47 | $164 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
200 | $0 | $5 |
| Complex chronic care management, first 60 minutes This service involves clinical staff time directed by a healthcare professional to manage two or more chronic conditions over a calendar month. It covers the first 60 minutes of this coordinated care effort. |
144 | $102 | $345 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
143 | $0 | $10 |
| Additional chronic care management time, 60 minutes This service covers an additional 60 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions, billed per calendar month. |
130 | $55 | $181 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
125 | $36 | $124 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
120 | $11 | $37 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
114 | $80 | $333 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
92 | $9 | $50 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
56 | $126 | $434 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
52 | $46 | $153 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
43 | $88 | $310 |
| Injection, methylprednisolone acetate, 40 mg | 43 | $6 | $50 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
38 | $241 | $956 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
35 | $1 | $18 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
34 | $181 | $804 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
30 | $94 | $407 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
29 | $360 | $1,229 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
28 | $198 | $682 |
| Fluoroscopic guidance for needle placement Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure. |
28 | $91 | $310 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
17 | $89 | $299 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
14 | $168 | $677 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$20,627
Total received (2018-2024)
Avg $2,947/year across 7 years
Top 2% in TX for anesthesiology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
65
Companies
436
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,600
2023
$779
2022
$2,049
2021
$8,280
2020
$973
2019
$3,295
2018
$2,652
Payments by company (2024)
Curonix LLC
$773
SI-BONE, INC.
$677
PAINTEQ LLC
$339
Medtronic, Inc.
$239
Collegium Pharmaceutical, Inc.
$212
ABBVIE INC.
$124
PFIZER INC.
$74
Azurity Pharmaceuticals, Inc.
$52
Nevro Corp.
$30
Fidia Pharma USA Inc.
$27
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$22
Averitas Pharma Inc.
$16
Cumberland Pharmaceuticals, Inc.
$15
Top 3 companies account for 68.8% of 2024 payments
All-time payments by company (2018-2024) ›
Nalu Medical, Inc.
$5,835
Vertiflex, Inc.
$2,316
Abbott Laboratories
$2,236
Relievant Medsystems, Inc.
$852
Curonix LLC
$838
Spinal Simplicity, LLC
$834
Collegium Pharmaceutical, Inc.
$724
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$689
SI-BONE, INC.
$677
PAINTEQ LLC
$515
Medtronic, Inc.
$475
ABBVIE INC.
$448
Nevro Corp.
$386
GRT US Holding, Inc.
$375
Boston Scientific Corporation
$269
PFIZER INC.
$245
AbbVie Inc.
$222
Amgen Inc.
$177
ARBOR PHARMACEUTICALS, INC.
$171
RedHill Biopharma Inc.
$142
Scilex Pharmaceuticals Inc.
$141
Allergan, Inc.
$126
BOSTON SCIENTIFIC CORPORATION
$123
Biohaven Pharmaceutical Holding Company Ltd.
$116
Azurity Pharmaceuticals, Inc.
$108
Novartis Pharmaceuticals Corporation
$91
Biohaven Pharmaceuticals, Inc.
$91
SpineSmith Holdings, LLC
$88
Medtronic USA, Inc.
$84
SCILEX PHARMACEUTICALS INC.
$77
Sentynl Therapeutics, Inc.
$68
AstraZeneca Pharmaceuticals LP
$68
Teva Pharmaceuticals USA, Inc.
$65
US WorldMeds, LLC
$59
Arbor Pharmaceuticals, Inc.
$54
TerSera Therapeutics LLC
$48
Stimwave Technologies Incorporated
$47
Organogenesis Inc.
$47
Kaleo, Inc.
$47
Purdue Pharma L.P.
$46
Lilly USA, LLC
$45
Avanos Medical
$43
Electronic Waveform Lab, Inc.
$41
Vertos Medical, Inc.
$40
Averitas Pharma Inc.
$34
Pernix Therapeutics Holdings, Inc.
$32
Assertio Therapeutics, Inc.
$30
IBSA Pharma Inc.
$29
DePuy Synthes Sales Inc.
$29
Fidia Pharma USA Inc.
$27
Hikma Pharmaceuticals USA
$24
Medtronic Vascular, Inc.
$24
Horizon Therapeutics plc
$23
Bausch Health US, LLC
$21
Xeris Pharmaceuticals, Inc.
$19
AcelRx Pharmaceuticals, Inc.
$19
Daiichi Sankyo Inc.
$18
Innovation Technologies Inc
$17
West Therapeutics Development, LLC
$16
Cumberland Pharmaceuticals, Inc.
$15
AbbVie, Inc.
$15
Shionogi Inc
$15
INSYS Therapeutics Inc
$14
Allergan Inc.
$12
Amniox Medical, Inc.
$11
Top 3 companies account for 50.4% of all-time payments
Associated products mentioned in payments ›
ADAPTIVESTIM · AIMOVIG · AJOVY · ASCENDA · AXIUM · Aemcolo · Aimovig · Axium INS DRG IPG · Axium Sheath Braided DRG · BOTOX · Belbuca · COOLIEF COOLED RADIOFREQUENCY · COOLIEF* COOLED RADIOFREQUENCY · ClosureFast · DSUVIA · EMGALITY · Evzio · GENERAL PAIN MANAGEMENT · GENERAL - PAIN MANAGEMENT · GENERAL - VASCULAR INTERVENTION · Gralise · HA MINUTEMAN G3-R · HORIZANT · HYMOVIS · Horizant · Humira · IFUSE IMPLANT SYSTEM · INTELLIS · INTELLIS ADAPTIVESTIM · IRRISEPT · Intracept · KEVEYIS · KRISTALOSE · Kloxxado · LUCEMYRA · LYRICA · Lazanda · Levorphanol · Levorphanol Tartrate · Licart · Lucemyra/Lofexidine · MIGRANAL · MONOVISC · MOVANTIK · Morphabond ER · Movantik · NEOX · NURTEC ODT · Nalu Neurostimulation System · Neuromodulation Dspsbls and Accs · NuCel/Matrix · Nucynta · ORTHOVISC · Omnia · PAINTEQ · PENNSAID · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PRIALT · PROCLAIM · Proclaim Family of SCS IPGs · Proclaim IPG · Prodigy Family of SCS IPGs · QULIPTA · QUTENZA · Qutenza · RELISTOR · RELISTOR ORAL · SUBSYS · SYMPROIC · SYNCHROMED · Senza · Senza Spinal Cord Stimulation System · StimQ Receiver Stimulator Kit Channel A US w/Receiver · Superion ISS · Superion Indirect Decompression System · Symproic · UBRELVY · V-LOC 180 · VENASEAL · WAVEWRITER ALPHA · WaveWriter Alpha Prime 16 · XTAMPZA · Xtampza ER · ZOHYDRO ER · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · mild Device Kit · movantik · talicia
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Anesthesiologists in nearby ZIP areas
1,045
County median income
$95,155
Nearest hospital to ZIP centroid (approximate)
HCA HOUSTON HEALTHCARE PEARLAND
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lafleur is a clinical cardiology specialist, with above-average Medicare volume (top 1% in TX), with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lafleur experienced with bupivacaine injection, 0.5 mg?
Based on Medicare claims data, Dr. Lafleur performed 1,380 bupivacaine injection, 0.5 mg services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Lafleur receive payments from pharmaceutical companies?
Yes. Dr. Lafleur received a total of $20,627 from 65 companies across 436 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lafleur's costs compare to other anesthesiologists in Pearland?
Dr. Lafleur's average Medicare payment per service is $36. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lafleur) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Anesthesiologists in Pearland
Browse anesthesiologists in Pearland ranked by procedure volume and transparency data.
Highest volume
Top Anesthesiologists in TX
Anesthesiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Anesthesiologists in TX
Which TX anesthesiologists receive the most from drug and device companies.
By company
Nalu Medical, Inc. Payments to Doctors
See all physicians who received payments from Nalu Medical, Inc.
By company
Vertiflex, Inc. Payments to Doctors
See all physicians who received payments from Vertiflex, Inc.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology